These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4797286)

  • 21. Paradoxical dextroamphetamine response.
    Arnold LE
    Psychosomatics; 1981 Sep; 22(9):805. PubMed ID: 7313058
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative time-dependent changes in sensitivity to locomotor effects of d-amphetamine in mice with caudate, hippocampal or frontal cortical lesions.
    Glick SD; Marsanico RG
    Arch Int Pharmacodyn Ther; 1974 May; 209(1):80-5. PubMed ID: 4606367
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of the substantia nigra in the locomotor stimulant action of amphetamine.
    Costall B; Naylor RJ
    Br J Pharmacol; 1973 Sep; 49(1):29-36. PubMed ID: 4787564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heat production and heat loss in d-amphetamine hyperthermia in aggregated Swiss Webster and BDF mice.
    Craigmill AL; Kupferberg HJ; Miller JW
    Toxicol Appl Pharmacol; 1973 Nov; 26(3):362-9. PubMed ID: 4767574
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of l-, d-, and parahydroxy-amphetamine on locomotor activity and wall climbing in rats of different ages.
    Bauer RH
    Pharmacol Biochem Behav; 1980 Aug; 13(2):155-65. PubMed ID: 7413685
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison between locomotor activity changes produced by phencyclidine and D-amphetamine in CD-1 male mice.
    Stavchansky S; Riffee W; Geary R
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):189-202. PubMed ID: 4023408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amphetamine increases activity but not exploration in humans and mice.
    Minassian A; Young JW; Cope ZA; Henry BL; Geyer MA; Perry W
    Psychopharmacology (Berl); 2016 Jan; 233(2):225-33. PubMed ID: 26449721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of d-amphetamine upon open field behaviour in two inbred strains of mice.
    Moisset B; Welch BL
    Experientia; 1973 May; 29(5):625-6. PubMed ID: 4730313
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of d-amphetamine on behavioral and autonomic thermoregulation in mice.
    Bushnell PJ; Gordon CJ
    Pharmacol Biochem Behav; 1987 Jul; 27(3):431-5. PubMed ID: 3659066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of low doses of d-amphetamine on drug-induced hyperactivity in the mouse.
    Hussey JS; Vincent ND; Davies JA
    Psychopharmacology (Berl); 1983; 81(4):327-31. PubMed ID: 6228947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of dextro-amphetamine and racemic-amphetamine in the treatment of the hyperkinetic syndrome or minimal brain dysfunction.
    Gross MD
    Dis Nerv Syst; 1976 Jan; 37(1):14-6. PubMed ID: 1106966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global 5-HT depletion attenuates the ability of amphetamine to decrease impulsive choice on a delay-discounting task in rats.
    Winstanley CA; Dalley JW; Theobald DEH; Robbins TW
    Psychopharmacology (Berl); 2003 Nov; 170(3):320-331. PubMed ID: 12955303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Locomotor depressant action of indole aldoxime and its antagonism by d-amphetamine.
    Banna NR; Pilcher CW
    Neuropharmacology; 1980 Jan; 19(1):103-6. PubMed ID: 7360324
    [No Abstract]   [Full Text] [Related]  

  • 35. How amphetamine acts in minimal brain dysfunction.
    Snyder SH; Meyerhoff JL
    Ann N Y Acad Sci; 1973 Feb; 205():310-20. PubMed ID: 4570236
    [No Abstract]   [Full Text] [Related]  

  • 36. [Locomotor activity and expression of c-Fos protein in the brain of C57BL and Balb/c mice: effects of D-amphetamine and sydnocarb].
    Novoselov IA; Cherepov AB; Raevskiĭ KS; Anokhin KV
    Eksp Klin Farmakol; 2002; 65(5):18-21. PubMed ID: 12596507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levoamphetamine vs dextroamphetamine in minimal brain dysfunction. Replication, time response, and differential effect by diagnostic group and family rating.
    Arnold LE; Huestis RD; Smeltzer DJ; Scheib J; Wemmer D; Colner G
    Arch Gen Psychiatry; 1976 Mar; 33(3):292-301. PubMed ID: 769721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of lead, d-amphetamine, and time of day on activity levels in the mouse.
    Dolinsky Z; Fink E; Burright RG; Donovick PJ
    Pharmacol Biochem Behav; 1981 Jun; 14(6):877-80. PubMed ID: 7255522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium.
    Gould TD; O'Donnell KC; Picchini AM; Manji HK
    Neuropsychopharmacology; 2007 Jun; 32(6):1321-33. PubMed ID: 17151598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. alpha(2A)-Adrenoceptors regulate d-amphetamine-induced hyperactivity and behavioural sensitization in mice.
    Juhila J; Honkanen A; Sallinen J; Haapalinna A; Korpi ER; Scheinin M
    Eur J Pharmacol; 2005 Jul; 517(1-2):74-83. PubMed ID: 15978573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.